See also:
online pharmacy viagra |
Biosimilar (of Rituxan) Under Trial For Rheumatoid arthritis
Teva pharmaceutical has annousced to develop biosimilar of Rituxan. Rituxan, first introduced by Roche, treats in new unique way called Monoclonol Antibody Therapy. Since specific mAb can be created for most of diseases, mAb therapy is seen as future
(
Read more... )